These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Schlienz NJ; Lee DC; Stitzer ML; Vandrey R Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485 [TBL] [Abstract][Full Text] [Related]
23. Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands. Freeman TP; van der Pol P; Kuijpers W; Wisselink J; Das RK; Rigter S; van Laar M; Griffiths P; Swift W; Niesink R; Lynskey MT Psychol Med; 2018 Oct; 48(14):2346-2352. PubMed ID: 29382407 [TBL] [Abstract][Full Text] [Related]
24. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Bossong MG; Niesink RJ Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444 [TBL] [Abstract][Full Text] [Related]
25. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500 [TBL] [Abstract][Full Text] [Related]
26. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154 [TBL] [Abstract][Full Text] [Related]
27. Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Kuepper R; Morrison PD; van Os J; Murray RM; Kenis G; Henquet C Schizophr Res; 2010 Aug; 121(1-3):107-17. PubMed ID: 20580531 [TBL] [Abstract][Full Text] [Related]
28. Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls. Cousijn J; Vingerhoets WA; Koenders L; de Haan L; van den Brink W; Wiers RW; Goudriaan AE Addict Biol; 2014 Mar; 19(2):282-93. PubMed ID: 24589297 [TBL] [Abstract][Full Text] [Related]
29. Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists. Gerra G; Zaimovic A; Gerra ML; Ciccocioppo R; Cippitelli A; Serpelloni G; Somaini L Recent Pat CNS Drug Discov; 2010 Jan; 5(1):46-52. PubMed ID: 19832688 [TBL] [Abstract][Full Text] [Related]
30. Have we been ignoring the elephant in the room? Seven arguments for considering the cerebellum as part of addiction circuitry. Miquel M; Vazquez-Sanroman D; Carbo-Gas M; Gil-Miravet I; Sanchis-Segura C; Carulli D; Manzo J; Coria-Avila GA Neurosci Biobehav Rev; 2016 Jan; 60():1-11. PubMed ID: 26602022 [TBL] [Abstract][Full Text] [Related]
31. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial. Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160 [TBL] [Abstract][Full Text] [Related]
32. [Effects of oral cannabis and dronabinol on driving capacity]. Giroud C; Augsburger M; Favrat B; Menetrey A; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mathieu S; Castella V; Hazekamp A; Mangin P Ann Pharm Fr; 2006 May; 64(3):161-72. PubMed ID: 16710114 [TBL] [Abstract][Full Text] [Related]
33. [Cannabis use and cannabis use disorders]. Hoch E; Preuss UW Nervenarzt; 2024 Sep; 95(9):781-796. PubMed ID: 39134752 [TBL] [Abstract][Full Text] [Related]
34. Deconstructing the neurobiology of cannabis use disorder. Ferland JN; Hurd YL Nat Neurosci; 2020 May; 23(5):600-610. PubMed ID: 32251385 [TBL] [Abstract][Full Text] [Related]
35. [Cannabis and cannabinoids as drugs]. Khiabani HZ; Mørland J Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810 [TBL] [Abstract][Full Text] [Related]
36. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction. Dhawan K; Kumar S; Sharma A J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005 [TBL] [Abstract][Full Text] [Related]
37. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information. Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081 [TBL] [Abstract][Full Text] [Related]
38. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. Cohen M; Rasser PE; Peck G; Carr VJ; Ward PB; Thompson PM; Johnston P; Baker A; Schall U Int J Neuropsychopharmacol; 2012 Apr; 15(3):297-307. PubMed ID: 21557880 [TBL] [Abstract][Full Text] [Related]
39. Unravelling the landscape of Preto MC; Kortas GT; Blaas IK; Lassi DLS; Waisman Campos M; Torales J; Ventriglio A; de Azevedo-Marques Périco C; de Andrade AG; Castaldelli-Maia JM Int Rev Psychiatry; 2023; 35(5-6):434-449. PubMed ID: 38299652 [TBL] [Abstract][Full Text] [Related]
40. Up in Smoke: The Impacts of Marijuana During Pregnancy. McPherson C Neonatal Netw; 2023 Jul; 42(4):222-232. PubMed ID: 37491043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]